HWAM
Hennion & Walsh Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
172,579
-7,973
| -4% | -$5.72K | 0.01% | 905 |
|
|
2025
Q1 | $265K | Sell |
180,552
-7,221
| -4% | -$10.6K | 0.01% | 784 |
|
|
2024
Q4 | $832K | Buy |
187,773
+16,962
| +10% | +$75.1K | 0.04% | 508 |
|
|
2024
Q3 | $704K | Buy |
170,811
+41,162
| +32% | +$170K | 0.03% | 533 |
|
|
2024
Q2 | $845K | Buy |
129,649
+118,462
| +1,059% | +$772K | 0.04% | 466 |
|
|
2024
Q1 | $97.4K | Sell |
11,187
-87
| -0.8% | -$758 | 0.01% | 834 |
|
|
2023
Q4 | $129K | Sell |
11,274
-242
| -2% | -$2.77K | 0.01% | 802 |
|
|
2023
Q3 | $111K | Sell |
11,516
-210
| -2% | -$2.02K | 0.01% | 781 |
|
|
2023
Q2 | $125K | Buy |
+11,726
| New | +$125K | 0.01% | 778 |
|
|
2022
Q4 | – | Sell |
-13,326
| Closed | -$138K | – | 785 |
|
|
2022
Q3 | $138K | Sell |
13,326
-482
| -3% | -$4.99K | 0.01% | 740 |
|
|
2022
Q2 | $159K | Sell |
13,808
-391
| -3% | -$4.5K | 0.01% | 738 |
|
|
2022
Q1 | $179K | Sell |
14,199
-836
| -6% | -$10.5K | 0.01% | 749 |
|
|
2021
Q4 | $175K | Buy |
+15,035
| New | +$175K | 0.01% | 727 |
|
|
2021
Q3 | – | Sell |
-17,294
| Closed | -$223K | – | 735 |
|
|
2021
Q2 | $223K | Buy |
17,294
+4,411
| +34% | +$56.9K | 0.01% | 688 |
|
|
2021
Q1 | $144K | Buy |
+12,883
| New | +$144K | 0.01% | 683 |
|